Literature DB >> 6124713

Antimalarial activity of mefloquine and qinghaosu.

J B Jiang, G Q Li, X B Guo, Y C Kong, K Arnold.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6124713     DOI: 10.1016/s0140-6736(82)90268-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  39 in total

1.  Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.

Authors:  A Moreno; E Badell; N Van Rooijen; P Druilhe
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  From branch to bedside: Youyou Tu is awarded the 2011 Lasker~DeBakey Clinical Medical Research Award for discovering artemisinin as a treatment for malaria.

Authors:  Ushma S Neill
Journal:  J Clin Invest       Date:  2011-10       Impact factor: 14.808

3.  Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.

Authors:  Jin Guo; Armand W Guiguemde; Annael Bentura-Marciano; Julie Clark; Richard K Haynes; Wing-Chi Chan; Ho-Ning Wong; Nicholas H Hunt; R Kiplin Guy; Jacob Golenser
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

Review 4.  Tropical medicine.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

Review 5.  Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.

Authors:  N J White
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

Review 6.  Clinical pharmacokinetics of antimalarial drugs.

Authors:  N J White
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

Review 7.  Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  K J Palmer; S M Holliday; R N Brogden
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 8.  New antimalarials. A risk-benefit analysis.

Authors:  F Nosten; R N Price
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

9.  Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.

Authors:  J Karbwang; K Na-Bangchang; A Thanavibul; D Bunnag; T Chongsuphajaisiddhi; T Harinasuta
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

10.  Artemisinin-naphthoquine combination (ARCO) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy.

Authors:  Francis W Hombhanje; David Linge; Adolf Saweri; Cynthia Kuanch; Robert Jones; Stephen Toraso; Jacobed Geita; Andrew Masta; Isi Kevau; Gilbert Hiawalyer; Mathias Sapuri
Journal:  Malar J       Date:  2009-08-12       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.